about
Human umbilical cord blood-derived mesenchymal stem cells promote vascular growth in vivoComparison of two preclinical myocardial infarct models: coronary coil deployment versus surgical ligationEngineered 3D bioimplants using elastomeric scaffold, self-assembling peptide hydrogel, and adipose tissue-derived progenitor cells for cardiac regeneration.Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.Fast-proliferating adipose tissue mesenchymal-stromal-like cells for therapyIn vitro comparative study of two decellularization protocols in search of an optimal myocardial scaffold for recellularization.Postinfarction Functional Recovery Driven by a Three-Dimensional Engineered Fibrin Patch Composed of Human Umbilical Cord Blood-Derived Mesenchymal Stem CellsNeoinnervation and neovascularization of acellular pericardial-derived scaffolds in myocardial infarcts.A bird's-eye view of cell therapy and tissue engineering for cardiac regeneration.Three-Dimensional Cultures of Human Subcutaneous Adipose Tissue-Derived Progenitor Cells Based on RAD16-I Self-Assembling Peptide.Update: Innovation in cardiology (IV). Cardiac tissue engineering and the bioartificial heart.Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents.Physiological conditioning by electric field stimulation promotes cardiomyogenic gene expression in human cardiomyocyte progenitor cells.Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells.In vivo bioluminescence imaging of cell differentiation in biomaterials: a platform for scaffold development.Bioluminescence imaging of cardiomyogenic and vascular differentiation of cardiac and subcutaneous adipose tissue-derived progenitor cells in fibrin patches in a myocardium infarct model.A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.New insights into lipid raft function regulating myocardial vascularization competency in human idiopathic dilated cardiomyopathy.Effect of aging on the pluripotential capacity of human CD105+ mesenchymal stem cells.Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord.Electrical stimulation of cardiac adipose tissue-derived progenitor cells modulates cell phenotype and genetic machinery.Identification of cardiomyogenic lineage markers in untreated human bone marrow-derived mesenchymal stem cells.The developmental pattern of myotubes in spinal muscular atrophy indicates prenatal delay of muscle maturation.Implication of fetal SMN2 expression in type I SMA pathogenesis: protection or pathological gain of function?Downregulation of Bcl-2 proteins in type I spinal muscular atrophy motor neurons during fetal development.FGF-4 increases in vitro expansion rate of human adult bone marrow-derived mesenchymal stem cells.Chimerism and microchimerism of the human heart: evidence for cardiac regeneration.Online monitoring of myocardial bioprosthesis for cardiac repairPost-infarction scar coverage using a pericardial-derived vascular adipose flap. Pre-clinical resultsCholine acetyltransferase expression does not identify early pathogenic events in fetal SMA spinal cordIdiopathic dilated cardiomyopathy exhibits defective vascularization and vessel formation
P50
Q27336125-5029E940-4A41-4D90-9B54-7C4D9AF09A1EQ33718007-22FFEC94-CF0E-4A72-94E9-5DC6D8A28D78Q33758005-F125419F-F378-43BA-BAE0-74A45DAFA8FAQ34243638-78F1613D-F675-4D11-AD44-07AB35B7840BQ34532767-C214FEFF-C5C9-41A0-A104-28378F49DAB9Q35662994-F971DD9C-A349-45A6-A688-C44C3AF090B6Q35878873-E22D7285-1E45-4AF1-997F-CF7D9287FD51Q35930186-0DC763AF-36F5-4ADA-9DC2-B23D1A0AE91BQ38006734-80FB4A65-8832-4CDA-B416-BB2A8BC09925Q38805878-027C3B53-03B5-4E88-955D-81087D35D373Q39202163-869C9129-6B2D-4A76-B907-3BD47EDCF447Q39847147-9D7264F0-F6CB-4DEB-804C-AA753ABDB13FQ43088330-5D9F5BD4-DB32-428E-8F5A-7411E39F60E5Q43187597-969B0FA9-4EBE-47DD-A118-5F9F4C4677D5Q43234438-638BB91F-A586-4C5A-A3AA-FF39C341DBE2Q44209749-67B2A6D0-215E-42B7-A7CD-39D8A3ACA204Q44519563-51A8E91C-5E97-452C-BA36-927BE773945BQ45219859-2FBB5C76-B264-4E6A-8726-168A927D9B24Q46968356-1CE1EB88-5DA2-485E-9133-365D0ADAFAD3Q48572251-7A62534A-4816-40E2-AAD6-1AD0382FDF31Q50494953-AFBF7500-B2AD-482C-BDB1-EF673199F6A7Q51295630-5B62BFCB-52E6-4BE7-ABDF-644B95B8CB3FQ51932605-B80A7393-ECE8-4B25-8913-DF5CB02947E4Q52053569-9B2F4348-AD76-4E4A-ABC2-F0082966D3D8Q52106126-70FD9A3A-B4DB-4DDF-8EC0-F9A9D75A1FC8Q54428716-923D4F73-2162-4052-8CE5-F0735B3DABF7Q54561747-557C9C41-B051-4BE4-A78D-3BB974989603Q57429209-61490DDE-BDBD-4685-A20A-98E605F19EABQ58802899-5ABD9FE0-DE6D-45FA-8B30-6A0B64246139Q60619548-5EFEFD12-AD46-45FA-977D-CC7098C54D1DQ61833411-CB5BB755-2320-4719-885A-F4BFB0E7E3ED
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carolina Soler-Botija
@ast
Carolina Soler-Botija
@en
Carolina Soler-Botija
@es
Carolina Soler-Botija
@nl
Carolina Soler-Botija
@sl
type
label
Carolina Soler-Botija
@ast
Carolina Soler-Botija
@en
Carolina Soler-Botija
@es
Carolina Soler-Botija
@nl
Carolina Soler-Botija
@sl
prefLabel
Carolina Soler-Botija
@ast
Carolina Soler-Botija
@en
Carolina Soler-Botija
@es
Carolina Soler-Botija
@nl
Carolina Soler-Botija
@sl
P108
P106
P21
P31
P496
0000-0002-4584-9134